From evidence to policy: The Scottish national naloxone programme
From evidence to policy: The Scottish national naloxone programme
复制标题
DOI：
10.3109/09687637.2012.682232
复制
发表时间：
2012-01-01
影响因子：
1.9
通讯作者：
Robertson, Roy
中科院分区：
文献类型：
--
作者：
McAuley, Andrew;Best, David;Robertson, Roy
药物相关死亡（DRD）是全球主要的公共卫生问题，苏格兰的死亡率高于英国任何其他地区，也是欧洲最高的地区之一。旨在解决DRD率上升的最重要的公共卫生干预措施之一是分发阿片类拮抗剂纳洛酮用于同伴管理。苏格兰政府于2010年制定了一项国家纳洛酮计划，旨在降低DRD的水平。相比之下，该方案的全国覆盖范围是独一无二的，是药物滥用公共卫生方面的一项重要发展。本文旨在描述这一具有里程碑意义的公共卫生计划的历程，详细介绍促进其创建的研究，宣传和政策贡献。还将介绍纳洛酮在其他国家的使用情况，讨论在其他地方采用类似国家方案的障碍。
Drug-related death (DRD) is a major public health problem globally, with rates in Scotland higher than any other UK region and among the highest in Europe. One of the most important public health interventions to emerge aimed at tackling rising DRD rates is the distribution of naloxone, the opioid antagonist, for peer administration. The Scottish Government established a national naloxone programme in 2010 aimed at reducing the increasing levels of DRD. The national coverage of the programme is unique by comparison and is an important development in substance misuse public health. This review aims to describe the journey to this landmark public health programme, detailing the research, advocacy and policy contributions that facilitated its creation. The use of naloxone in other countries will also be described, discussing the barriers in place to adopting similar national programmes elsewhere.